ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

EVOK Evoke Pharma Inc

0,4577
-0,0223 (-4,65%)
Nach Börsenschluss
Zuletzt aktualisiert: 22:30:00
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Evoke Pharma Inc EVOK NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,0223 -4,65% 0,4577 22:30:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,453 0,4104 0,55 0,4577 0,48
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
17.4.202414:30GLOBEEvoke Pharma to Host Virtual Key Opinion Leader (KOL)..
21.3.202421:15GLOBEEvoke Pharma Announces Senior Leadership Transition with..
14.3.202421:05GLOBEEvoke Pharma Reports Fourth Quarter and Full Year 2023..
07.3.202422:10GLOBEEvoke Pharma to Report Fourth Quarter and Full Year 2023..
23.2.202422:15EDGAR2Form 8-K - Current report
20.2.202422:38EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14.2.202415:00EDGAR2Form 8-K - Current report
14.2.202413:30GLOBEEvoke Pharma Announces Closing of $7.5 Million Public..
09.2.202423:15EDGAR2Form 8-K - Current report
09.2.202423:14EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
09.2.202413:30GLOBEEvoke Pharma Announces Pricing of Underwritten Public..
09.2.202406:15EDGAR2Form EFFECT - Notice of Effectiveness
08.2.202412:50EDGAR2Form S-1/A - General form for registration of securities..
11.1.202403:38EDGAR2Form S-1/A - General form for registration of securities..
04.1.202422:30EDGAR2Form S-1/A - General form for registration of securities..
19.12.202314:30EDGAR2Form S-1/A - General form for registration of securities..
15.12.202322:30EDGAR2Form S-1/A - General form for registration of securities..
29.11.202315:00EDGAR2Form 8-K - Current report
27.11.202322:30EDGAR2Form 8-K - Current report
27.11.202314:30GLOBEEvoke Pharma Announces FDA Orange Book Listing of New GIMOTI..
22.11.202322:15EDGAR2Form 8-K - Current report
14.11.202314:30GLOBEUnited States Patent and Trademark Office (USPTO) Grants..
09.11.202322:30EDGAR2Form S-1 - General form for registration of securities under..
09.11.202315:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.11.202315:00EDGAR2Form 8-K - Current report
09.11.202314:30GLOBEEvoke Pharma Reports Third Quarter 2023 Financial Results
01.11.202313:30EDGAR2Form 8-K - Current report
31.10.202313:30GLOBEEvoke Pharma & EVERSANA Unveil Cost Savings Real-World Data..
18.10.202314:30GLOBEEvoke Pharma’s Abstract Entitled “Superiority of Nasal Spray..
12.10.202322:30EDGAR2Form 8-K - Current report
14.9.202314:30GLOBEEvoke Pharma Receives Notice of Allowance from USPTO for..
11.8.202315:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
10.8.202315:03EDGAR2Form 8-K - Current report
10.8.202315:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10.8.202314:30GLOBEEvoke Pharma Reports Second Quarter 2023 Financial Results
07.8.202314:30GLOBEEvoke Pharma and EVERSANA Announce Abstract Acceptance at..
25.7.202314:30GLOBEEvoke Pharma and EVERSANA Announce Abstract Selection for..
21.7.202315:00EDGAR2Form 8-K - Current report
14.6.202314:30GLOBEEvoke Pharma to Host First Key Opinion Leader Webinar on..
15.5.202322:05GLOBEEvoke Pharma Reports First Quarter 2023 Financial Results
09.5.202313:00GLOBEReal-World Data Presented by Evoke Pharma and EVERSANA at..
04.5.202314:30GLOBEEvoke Pharma’s Real-World Healthcare Utilization Data..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock